Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Adam Garsa, MD

    AddressGNH 1100 N. State Street
    Health Sciences Campus
    Los Angeles California 90033
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr.Garsa is an Assistant Professor of Clinical Radiation Oncology at USC Norris Cancer Hospital and USC + Los Angeles County Medical Center. He joined USC in June 2017.

      Dr. Garsa graduated with honors from Washington University in St. Louis with a Bachelor of Arts degree in biology. He received his medical degree from the University of Pittsburgh School of Medicine, and completed his residency in radiation oncology at Washington University School of Medicine. In addition, he competed a CNS radiation oncology fellowship in at the University of California San Francisco.

      After completing his clinical fellowship, Dr. Garsa was on the faculty at UCSF specializing in the treatment of head and neck, CNS, skin, and lung cancers. Dr. Garsa has presented and published multiple studies investigating advanced imaging technologies and radiation therapy techniques to allow for maximal therapeutic effect while minimizing treatment side effects.

      Clinical Expertise: Head and Neck, CNS, Skin Cancer, and SBRT

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Vasudevan HN, Raleigh DR, Johnson J, Garsa A, Theodosopoulos PV, Aghi MK, Ames C, McDermott MW, Barani IJ, Braunstein SE. Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy. Front Surg. 2017; 4:35. PMID: 28691010.
        View in: PubMed
      2. Manyam BV, Garsa A, Chin RI, Reddy CA, Gastman B, Thorstad W, Yom SS, Nussenbaum B, Wang SJ, Vidimos AT, Koyfman SA. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Cancer. 2017 Jun 01; 123(11):2054-2060. PMID: 28171708.
        View in: PubMed
      3. Shugard E, Chen J, Quivey JM, Glastonbury CM, Khanafshar E, Garsa A, George JR, Yom SS. Does radiation dose matter in thyroid cancer?: Patterns of local-regional failure in recurrent and metastatic well-differentiated thyroid cancers treated with dose-painted intensity-modulated radiation therapy. J Med Imaging Radiat Oncol. 2016 Aug; 60(4):560-7. PMID: 27020481.
        View in: PubMed
      4. Garsa A, Badiyan SN, DeWees T, Simpson JR, Huang J, Drzymala RE, Barani IJ, Dowling JL, Rich KM, Chicoine MR, Kim AH, Leuthardt EC, Robinson CG. Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases. Int J Radiat Oncol Biol Phys. 2014 Oct 01; 90(2):407-13. PMID: 25084610.
        View in: PubMed
      5. Garsa A, Verma V, Michalski JM, Gay HA. Transperineal ultrasound-guided implantation of electromagnetic transponders in the prostatic fossa for localization and tracking during external beam radiation therapy. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):415-21. PMID: 25407864.
        View in: PubMed
      6. Badiyan SN, Rao RC, Apicelli AJ, Acharya S, Verma V, Garsa A, DeWees T, Speirs CK, Garcia-Ramirez J, Esthappan J, Grigsby PW, Harbour JW. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):801-5. PMID: 24462385.
        View in: PubMed
      7. Garsa A, Ferraro DJ, DeWees TA, Deshields TL, Margenthaler JA, Cyr AE, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Ochoa LL, Zoberi I. A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2013 Dec 01; 87(5):1043-50. PMID: 24161428; PMCID: PMC3920547.
      8. Garsa A, Chang AJ, Dewees T, Spencer CR, Adkins DR, Dehdashti F, Gay HA, Thorstad WL. Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma. J Radiat Oncol. 2013 Mar; 2(1):27-34. PMID: 24563726.
        View in: PubMed
      9. Badiyan SN, Bierhals AJ, Olsen JR, Creach KM, Garsa A, Dewees T, Bradley JD, Robinson CG. Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis. Radiat Oncol. 2013 Jan 03; 8:4. PMID: 23286648; PMCID: PMC3552761.
      10. Garsa A, Ferraro DJ, DeWees T, Margenthaler JA, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Zoberi I. Cosmetic analysis following breast-conserving surgery and adjuvant high-dose-rate interstitial brachytherapy for early-stage breast cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):965-70. PMID: 23058060; PMCID: PMC3963512.
      11. Garsa A, Ferraro DJ, Dewees T, Margenthaler JA, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Zoberi I. Analysis of fat necrosis after adjuvant high-dose-rate interstitial brachytherapy for early stage breast cancer. Brachytherapy. 2013 Mar-Apr; 12(2):99-106. PMID: 22726878; PMCID: PMC3929056.
      12. Ferraro DJ, Garsa A, DeWees TA, Margenthaler JA, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Zoberi I. Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation. Radiat Oncol. 2012 Mar 29; 7:53. PMID: 22458887; PMCID: PMC3359280.
      13. Cresci S, Jones PG, Sucharov CC, Marsh S, Lanfear DE, Garsa A, Courtois M, Weinheimer CJ, Wu J, Province MA, Kelly DP, McLeod HL, Spertus JA. Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes. Pharmacogenomics. 2008 Oct; 9(10):1403-17. PMID: 18855529; PMCID: PMC2586954.
      14. Garsa A, Andrade RS, Heron DE, Beriwal S, Kim H, Brandner E, Kuo G, Chen H, Gerszten K, Yue JN, Huq MS, Lee J, Lalonde R, Wu A. Four-dimensional computed tomography-based respiratory-gated whole-abdominal intensity-modulated radiation therapy for ovarian cancer: a feasibility study. Int J Gynecol Cancer. 2007 Jan-Feb; 17(1):55-60. PMID: 17291232.
        View in: PubMed
      15. Henningsson A, Marsh S, Loos WJ, Karlsson MO, Garsa A, Mross K, Mielke S, ViganĂ² L, Locatelli A, Verweij J, Sparreboom A, McLeod HL. Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel. Clin Cancer Res. 2005 Nov 15; 11(22):8097-104. PMID: 16299241.
        View in: PubMed
      16. Garsa A, McLeod HL, Marsh S. CYP3A4 and CYP3A5 genotyping by Pyrosequencing. BMC Med Genet. 2005 May 09; 6:19. PMID: 15882469; PMCID: PMC1142317.
      17. Marsh S, King CR, Garsa A, McLeod HL. Pyrosequencing of clinically relevant polymorphisms. Methods Mol Biol. 2005; 311:97-114. PMID: 16100402.
        View in: PubMed